The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant therapy with mFOLFOXIRI combined with camrelizumab and bevacizumab for microsatellite stable, locally advanced rectal cancer: A single-arm, open-label phase II study.
 
Xiaodong WANG
No Relationships to Disclose
 
Dandan Huang
No Relationships to Disclose
 
Yihong Xie
No Relationships to Disclose
 
Yuzhuo Xie
No Relationships to Disclose
 
Jingyi Shi
No Relationships to Disclose
 
Dongdong Hou
No Relationships to Disclose
 
Fang Du
No Relationships to Disclose
 
Yujuan Cao
No Relationships to Disclose
 
Qingkun Gao
No Relationships to Disclose
 
Yunfan Wang
No Relationships to Disclose
 
Juan Wang
No Relationships to Disclose
 
Zhaoya Gao
No Relationships to Disclose
 
Xiaowei Jin
No Relationships to Disclose
 
Meng Li
No Relationships to Disclose
 
Longying Hao
No Relationships to Disclose
 
Delin Wang
No Relationships to Disclose
 
Bin Zhang
No Relationships to Disclose
 
Gang Ren
No Relationships to Disclose
 
Ming Li
No Relationships to Disclose
 
Jin Gu
No Relationships to Disclose